In the wake of the Matrixx decision and the continued scrutiny of public companies, view the replay to learn what you need to consider in regard to disclosure and M&A transactions.

Our panel discussion covered:

• What impact will Matrixx have on the disclosure process for public companies?
• How can companies minimize the risk of securities litigation from their public disclosures and forward-looking statements?
• How have defendants fared in recent "missed earnings" and "false guidance" securities class actions?
• What are the current "hot claims" by plaintiffs' lawyers in securities class action
  and derivative suits?
• What are the best strategies for preventing or defeating a shareholder fiduciary
  duty class action to enjoin an M&A transaction?
• What can be done to prevent multiple suits in different venues?